Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 6/2018

01-06-2018 | Brief Communication

Improvement of Body Composition and Quality of Life Following Intragastric Balloon

Authors: Silvia Mansur Reimão, Maria Elizabeth Rossi da Silva, Gabriel Cairo Nunes, Luiz Henrique Mazzonetto Mestieri, Rosa Ferreira dos Santos, Eduardo Guimarães Hourneaux de Moura

Published in: Obesity Surgery | Issue 6/2018

Login to get access

Abstract

Background

The aim is to evaluate the effects of IGB in overweight or class I obese patients, by analyzing body composition and quality of life (QOL).

Methods

Prospective study including patients with BMI 27–34.9 kg/m2.body composition analysis (BCA) was performed before IGB implantation and its removal, after 6 months of treatment. QOL was assessed by the Short Form 36 (SF-36) Health Survey at baseline and after treatment.

Results

Forty patients were included in this study, but four were excluded. The total weight decreased by 12.29 kg after 6 months of use of IGB, which corresponds to loss of 13.69% of the total weight. There was a significant reduction in body fat mass and fat area. QOL improved in all eight sections analyzed (p < 0.001 to 0.041): functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects, and mental health.

Conclusions

IGB induces not only weight loss but changes in body composition through the reduction of body fat mass and fat area. Furthermore, it improves QOL.
Literature
1.
2.
Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19(8):1084–8.CrossRefPubMed
3.
Gottig S, Daskalakis M, Weiner S, et al. Analysis of safety and efficacy of intragastric balloon in extremely obese patients. Obes Surg. 2009;19(6):677–83.CrossRefPubMed
4.
Mathus-Vliegen EM. Intragastric balloon treatment for obesity: what does it really offer? Dig Dis. 2008;26(1):40–4.CrossRefPubMed
5.
6.
Mathus-Vliegen EM, Eichenberger RI. Fasting and meal-suppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg. 2014;24(1):85–94.CrossRefPubMed
7.
Wadden TA, Webb VL, Moran CH, et al. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125(9):1157–70.CrossRefPubMedPubMedCentral
8.
Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–438.e425.CrossRefPubMed
9.
Mui WL, Ng EK, Tsung BY, et al. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32.CrossRefPubMed
Metadata
Title
Improvement of Body Composition and Quality of Life Following Intragastric Balloon
Authors
Silvia Mansur Reimão
Maria Elizabeth Rossi da Silva
Gabriel Cairo Nunes
Luiz Henrique Mazzonetto Mestieri
Rosa Ferreira dos Santos
Eduardo Guimarães Hourneaux de Moura
Publication date
01-06-2018
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3209-9

Other articles of this Issue 6/2018

Obesity Surgery 6/2018 Go to the issue

Letter to the Editor

Gastrointestinal Stromal Tumor After Laparoscopic Sleeve Gastrectomy: Be Awake Before, During, and After a Bariatric Procedure

Letter to the Editor

Anemia and Bariatric Surgery: Results of a National French Survey on Administrative Data of 306,298 Consecutive Patients Between 2008 and 2016

Original Contributions

Analysis of Laparoscopic Sleeve Gastrectomy Learning Curve and Its Influence on Procedure Safety and Perioperative Complications

Original Contributions

Is Bariatric Surgery a Prophylaxis for Pelvic Floor Disorders?

Original Contributions

Inflammatory Bowel Disease Is Not a Contraindication for Bariatric Surgery

Original Contributions

Depression and Anxiety: Lack of Associations with an Inadequate Diet in a Sample of Pregnant Women with a History of Bariatric Surgery—a Multicenter Prospective Controlled Cohort Study